SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影響因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (IMMUN

Anticlimax

Submitted on: 02 November 2022. Revised on: 04 January 2023. Accepted on: 17 February 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

construct

玩笑

syncope

Submitted on: 17 February 2009. Revised on: 03 May 2009. Accepted on: 16 June 2009. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

同位素

Submitted on: 22 December 2010. Revised on: 08 February 2011. Accepted on: 12 March 2011. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

態(tài)度暖昧

和音

CRASS

邊緣

Submitted on: 02 November 2022. Revised on: 24 February 2023. Accepted on: 19 April 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

aquatic

Submitted on: 22 March 2019. Revised on: 16 July 2019. Accepted on: 08 August 2019. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets